0001203311-21-000053.txt : 20210813
0001203311-21-000053.hdr.sgml : 20210813
20210813213953
ACCESSION NUMBER: 0001203311-21-000053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210813
FILED AS OF DATE: 20210813
DATE AS OF CHANGE: 20210813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSEY ROGER D
CENTRAL INDEX KEY: 0001741836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 211174138
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-13
0
0001060736
Seagen Inc.
SGEN
0001741836
DANSEY ROGER D
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Medical Officer
Common Stock
2021-08-13
4
S
0
9900
156.58
D
74535
D
Common Stock
2021-08-13
4
S
0
100
157.25
D
74435
D
Reflects sales of common stock executed in multiple transactions at prices ranging from $156.25 to $157.23 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Elizabeth Bekiroglu For: Roger D Dansey
2021-08-13